55 related articles for article (PubMed ID: 9630842)
1. TL antigen is not linked to radioinduced thymic lymphoma.
Boudreau R; St-Pierre Y; Beauchemin C; Potworowski EF
Cell Immunol; 1998 Mar; 184(2):161-7. PubMed ID: 9630842
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic characterization of thymic prelymphoma cells of B10 mice treated with split-dose irradiation.
Muto M; Kubo E; Kamisaku H; Sado T
J Immunol; 1990 Feb; 144(3):849-53. PubMed ID: 2104913
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic and cellular events during radiation-induced thymic lymphomagenesis in the p53 heterozygous (+/-) B10 mouse.
Tanaka K; Watanabe K; Mori M; Kamisaku H; Tsuji H; Hirabayashi Y; Inoue T; Yoshida K; Aizawa S
Int J Radiat Biol; 2002 Mar; 78(3):165-72. PubMed ID: 11869471
[TBL] [Abstract][Full Text] [Related]
4. Development of prelymphoma cells committed to thymic lymphomas during radiation-induced thymic lymphomagenesis in B10 mice.
Muto M; Kubo E; Sado T
Cancer Res; 1987 Jul; 47(13):3469-72. PubMed ID: 3495331
[TBL] [Abstract][Full Text] [Related]
5. Characterization of thymic prelymphoma cells that develop during radiation-induced lymphomagenesis in B10 mice.
Muto M; Kubo E; Sado T; Yamagishi H
J Radiat Res; 1991 Dec; 32 Suppl 2():156-67. PubMed ID: 1823352
[TBL] [Abstract][Full Text] [Related]
6. The stromal gene encoding the CD274 antigen as a genetic modifier controlling survival of mice with γ-radiation-induced T-cell lymphoblastic lymphomas.
Santos J; González-Sánchez L; Villa-Morales M; Ors I; López-Nieva P; Vaquero C; González-Gugel E; Fernández-Navarro P; Roncero AM; Guenet JL; Montagutelli X; Fernández-Piqueras J
Oncogene; 2010 Sep; 29(38):5265-73. PubMed ID: 20639904
[TBL] [Abstract][Full Text] [Related]
7. Induction of tolerance to immunogenic tumor antigens associated with lymphomagenesis in HOX11 transgenic mice.
Rosic-Kablar S; Chan K; Reis MD; Dubé ID; Hough MR
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13300-5. PubMed ID: 11069299
[TBL] [Abstract][Full Text] [Related]
8. Expression of 44-kilodalton oncofetal antigen as a premalignancy marker in X irradiation-induced murine T-cell lymphoma.
Rohrer SD; Sarli RN; Barsoum AL; Hester RB; Coggin JH
J Natl Cancer Inst; 1992 Apr; 84(8):602-9. PubMed ID: 1556771
[TBL] [Abstract][Full Text] [Related]
9. [NK activity in C57BL/Ka mice during the development of radiation-induced lymphomas].
Noël A; Schaaf-Lafontaine N; Defresne MP; Boniver J
C R Seances Soc Biol Fil; 1985; 179(2):271-5. PubMed ID: 3160448
[TBL] [Abstract][Full Text] [Related]
10. Introduction of OX40 ligand into lymphoma cells elicits anti-lymphoma immunity in vivo.
Kaneko H; Hori T; Yanagita S; Kadowaki N; Uchiyama T
Exp Hematol; 2005 Mar; 33(3):336-43. PubMed ID: 15730857
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma.
Pilozzi E; Pulford K; Jones M; Müller-Hermelink HK; Falini B; Ralfkiaer E; Pileri S; Pezzella F; De Wolf-Peeters C; Arber D; Stein H; Mason D; Gatter K
J Pathol; 1998 Oct; 186(2):140-3. PubMed ID: 9924428
[TBL] [Abstract][Full Text] [Related]
12. Development of T-cell lymphomas in Emu-IEX-1 mice.
Zhang Y; Finegold MJ; Porteu F; Kanteti P; Wu MX
Oncogene; 2003 Oct; 22(44):6845-51. PubMed ID: 14534530
[TBL] [Abstract][Full Text] [Related]
13. Structural identity of the TL antigen homologues derived from strain 2 and strain 13 guinea pigs.
Surratt RS; Abruzzini LN; Zacheis MP; Cigen R; Schwartz BD
J Immunol; 1983 Sep; 131(3):1344-9. PubMed ID: 6604095
[TBL] [Abstract][Full Text] [Related]
14. Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression.
Voronov E; Weinstein Y; Benharroch D; Cagnano E; Ofir R; Dobkin M; White RM; Zoller M; Barak V; Segal S; Apte RN
Cancer Res; 1999 Mar; 59(5):1029-35. PubMed ID: 10070959
[TBL] [Abstract][Full Text] [Related]
15. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype.
de Mascarel A; Belleannée G; Stanislas S; Merlio C; Parrens M; Laharie D; Dubus P; Merlio JP
Am J Surg Pathol; 2008 May; 32(5):744-51. PubMed ID: 18360280
[TBL] [Abstract][Full Text] [Related]
16. Aberrant activation of interleukin-9 receptor and downstream Stat3/5 in primary T-cell lymphomas in vivo in susceptible B6 and resistant C3H mice.
Shang Y; Kakinuma S; Amasaki Y; Nishimura M; Kobayashi Y; Shimada Y
In Vivo; 2008; 22(6):713-20. PubMed ID: 19180996
[TBL] [Abstract][Full Text] [Related]
17. Stable expression of chimeric anti-CD3 receptors on mammalian cells for stimulation of antitumor immunity.
Liao KW; Chen BM; Liu TB; Tzou SC; Lin YM; Lin KF; Su CI; Roffler SR
Cancer Gene Ther; 2003 Oct; 10(10):779-90. PubMed ID: 14502231
[TBL] [Abstract][Full Text] [Related]
18. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
19. A new candidate site for a tumor suppressor gene involved in mouse thymic lymphomagenesis is located on the distal part of chromosome 4.
Santos J; Herranz M; Pérez de Castro I; Pellicer A; Fernández-Piqueras J
Oncogene; 1998 Aug; 17(7):925-9. PubMed ID: 9780010
[TBL] [Abstract][Full Text] [Related]
20. B7.1 immunogene therapy effectively activates CD(4+) tumor-infiltrating lymphocytes in the central nervous system in comparison with B7.2 gene therapy.
Ando H; Saio M; Ohe N; Tamakawa N; Yu H; Nakayama T; Yoshimura S; Kaku Y; Iwama T; Shinoda J; Sakai N; Takami T
Int J Oncol; 2002 Apr; 20(4):807-12. PubMed ID: 11894129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
